Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized trial of S-1 plus oxaliplatin vs S-1 plus cisplatin for advanced or recurrent gastric cancer
jRCT2080220988Phase 3
- Sponsor
- Yakult Honsha
- Start
- Jan 2010
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in gastric cancer (GC) comparing S-1 plus oxaliplatin with S-1 plus cisplatin (2 arms).
02
Drugs
oxaliplatincisplatintegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on jRCT2080220988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220988.